News 10 Mar 2026 Donor Interview: Professor Jae-Hyung Jang, Department of Chemical and Biomolecular Engineering (CTO of GluGene Therapeutics) 1. Could you please provide a brief self-introduction for the Yonseians and subscribers reading this article? I am Jae-Hyung Jang,… GluGene
News 24 Feb 2026 Rznomics and GluGene Therapeutics Partner to Develop Next-Generation RNA Gene Therapies Rznomics, a leader in RNA-based gene therapeutics, and GluGene Therapeutics, an innovator in Adeno-Associated Virus (AAV) vector engineering, have entered… GluGene
News 13 Oct 2025 GluGene Therapeutics Showcases a Data-driven AAV Engineering Platform for Next-Generation In Vivo Gene Therapy at ESGCT GluGene Therapeutics announced the presentation of four independent studies at the Annual Congress of the European Society of Gene &… GluGene
News 21 May 2025 GluGene Therapeutics Secures Initial Financial Investor Participation in Series A Financing Round GluGene Therapeutics, a biotechnology company developing advanced adeno-associated virus (AAV) platform technologies for next-generation gene therapies, announced that participation by… GluGene
News 29 Apr 2025 GluGene Therapeutics Publishes Breakthrough Precision-Targeted AAV Platform for Pulmonary Arterial Hypertension in Nature Biomedical Engineering GluGene Therapeutics announced the publication of its research demonstrating the potential for a fundamentally curative gene therapy for pulmonary arterial… GluGene
